NeuroOne Medical Technologies CorporationNMTCNASDAQ
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q4 2025 | 5.82% |
| Q3 2025 | 10.05% |
| Q2 2025 | -16.57% |
| Q1 2025 | -5.04% |
| Q4 2024 | 10.81% |
| Q3 2024 | -1.96% |
| Q2 2024 | -6.08% |
| Q1 2024 | -7.85% |
| Q4 2023 | 37.65% |
| Q3 2023 | -15.21% |
| Q2 2023 | 2.27% |
| Q1 2023 | 9.46% |
| Q4 2022 | -11.94% |
| Q3 2022 | 23.52% |
| Q2 2022 | -15.87% |
| Q1 2022 | 4.37% |
| Q4 2021 | 7.30% |
| Q3 2021 | -23.75% |
| Q2 2021 | 62.15% |
| Q1 2021 | 10.00% |
| Q4 2020 | -5.19% |
| Q3 2020 | 9.85% |
| Q2 2020 | 10.73% |
| Q1 2020 | -21.10% |
| Q4 2019 | 47.01% |
| Q3 2019 | -38.02% |
| Q2 2019 | 32.76% |
| Q1 2019 | 25.17% |
| Q4 2018 | 17.48% |
| Q3 2018 | -22.07% |
| Q2 2018 | -4.61% |
| Q1 2018 | 84.17% |
| Q4 2017 | -13.39% |
| Q3 2017 | -15.00% |
| Q2 2017 | 64.85% |
| Q1 2017 | 143.07% |
| Q4 2016 | 9310.97% |
| Q3 2016 | -86.24% |
| Q2 2016 | 221.66% |
| Q1 2016 | -70.46% |